Cardlytics Inc (NASDAQ: CDLX)’s stock price has soared by 2.21 in relation to previous closing price of 14.01. Nevertheless, the company has seen a gain of 4.91% in its stock price over the last five trading days. The Motley Fool reported 2024-04-02 that Cardlytics stock skyrocketed because its business showed improved trends. The company then refinanced some of its debt at a higher rate, which troubled investors.
Is It Worth Investing in Cardlytics Inc (NASDAQ: CDLX) Right Now?
CDLX has 36-month beta value of 1.47. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for CDLX is 40.72M, and currently, short sellers hold a 11.01% ratio of that float. The average trading volume of CDLX on April 10, 2024 was 1.72M shares.
CDLX’s Market Performance
CDLX’s stock has seen a 4.91% increase for the week, with a 80.58% rise in the past month and a 97.25% gain in the past quarter. The volatility ratio for the week is 7.03%, and the volatility levels for the past 30 days are at 11.68% for Cardlytics Inc . The simple moving average for the past 20 days is 7.23% for CDLX’s stock, with a 36.50% simple moving average for the past 200 days.
Analysts’ Opinion of CDLX
Many brokerage firms have already submitted their reports for CDLX stocks, with Craig Hallum repeating the rating for CDLX by listing it as a “Buy.” The predicted price for CDLX in the upcoming period, according to Craig Hallum is $18 based on the research report published on March 15, 2024 of the current year 2024.
Lake Street, on the other hand, stated in their research note that they expect to see CDLX reach a price target of $13. The rating they have provided for CDLX stocks is “Buy” according to the report published on November 29th, 2023.
Wells Fargo gave a rating of “Underweight” to CDLX, setting the target price at $13 in the report published on September 08th of the previous year.
CDLX Trading at 49.07% from the 50-Day Moving Average
After a stumble in the market that brought CDLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.21% of loss for the given period.
Volatility was left at 11.68%, however, over the last 30 days, the volatility rate increased by 7.03%, as shares surge +68.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +148.18% upper at present.
During the last 5 trading sessions, CDLX rose by +4.91%, which changed the moving average for the period of 200-days by +137.87% in comparison to the 20-day moving average, which settled at $13.65. In addition, Cardlytics Inc saw 55.48% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDLX starting from Temsamani Karim Saad, who sale 32,564 shares at the price of $13.69 back on Apr 02 ’24. After this action, Temsamani Karim Saad now owns 344,734 shares of Cardlytics Inc, valued at $445,801 using the latest closing price.
Lynton Nicholas Hollmeyer, the Chief Legal & Privacy Officer of Cardlytics Inc, sale 12,460 shares at $13.69 during a trade that took place back on Apr 02 ’24, which means that Lynton Nicholas Hollmeyer is holding 71,355 shares at $170,620 based on the most recent closing price.
Stock Fundamentals for CDLX
Current profitability levels for the company are sitting at:
- -0.28 for the present operating margin
- 0.43 for the gross margin
The net margin for Cardlytics Inc stands at -0.37. The total capital return value is set at -0.22. Equity return is now at value -77.77, with -21.29 for asset returns.
Based on Cardlytics Inc (CDLX), the company’s capital structure generated 0.66 points at debt to capital in total, while cash flow to debt ratio is standing at -0.0. The debt to equity ratio resting at 1.93. The interest coverage ratio of the stock is -14.32.
Currently, EBITDA for the company is -34.15 million with net debt to EBITDA at -4.0. When we switch over and look at the enterprise to sales, we see a ratio of 2.58. The receivables turnover for the company is 2.48for trailing twelve months and the total asset turnover is 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.31.
Conclusion
To put it simply, Cardlytics Inc (CDLX) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
